Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21433059

Comparison of Two Adalimumab Treatment Schedule Strategies for Moderate-to-Severe Crohn's Disease : Results From the CHARM Trial

Author
COLOMBEL, Jean-Frédéric1 ; SANDBORN, William J2 ; RUTGEERTS, Paul3 ; KAMM, Michael A4 ; YU, Andrew P5 ; WU, Eric Q5 ; POLLACK, Paul F6 ; LOMAX, Kathleen G6 ; JINGDONG CHAO7 ; MULANI, Parvez M7
[1] Department of Hepatogastroenterology, Hôpital Claude Huriez, Centre Hospitalier Universitaire de Lille, Lille, France
[2] Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States
[3] Department of Gastro-Enterologie, University Hospital of Gasthuisberg, Leuven, Belgium
[4] Department of Medicine, St Vincent's Hospital & Melbourne University, Melbourne, Victoria, Australia
[5] Analysis Group Inc, Boston, Massachusetts, United States
[6] Medical Affairs-Immunology, Abbott Laboratories, Parsippany, New Jersey, United States
[7] Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, Illinois, United States
Source

The American journal of gastroenterology. 2009, Vol 104, Num 5, pp 1170-1179, 10 p ; ref : 8 ref

ISSN
0002-9270
Scientific domain
Gastroenterology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Keyword (fr)
Adalimumab Antipsoriasique Antirhumatismal Entérite de Crohn Etude comparative Gastroentérologie Immunomodulateur Traitement Anti-TNF-alpha Anticorps monoclonal Anticytokine Cytokine Facteur nécrose tumorale α Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
Keyword (en)
Adalimumab Antipsoriatic agent Antirheumatic agent Crohn disease Comparative study Gastroenterology Immunomodulator Treatment Anti-Tumor Necrosis Factor-alpha Monoclonal antibody Anticytokine Cytokine Tumor necrosis factor α Inflammatory disease Digestive diseases Intestinal disease
Keyword (es)
Adalimumab Antipsoriásico Antireumático Enteritis Crohn Estudio comparativo Gastroenterología Inmunomodulador Tratamiento Anti-TNF alfa Anticuerpo monoclonal Anticitoquina Citoquina Factor necrosis tumoral α Enfermedad inflamatoria Aparato digestivo patología Intestino patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology

Discipline
Gastroenterology. Liver. Pancreas. Abdomen Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
21433059

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web